Krishnan Mahesh insider trades
Krishnan Mahesh has filed 7 Form 4s with the SEC that we hold, for Halozyme Therapeutics, INC. (HALO) (Director) and KDNY (Director). Across all of them we count 0 purchases worth $0 and 2 sales worth $569.1K reported on Form 4. In the last 12 months: 0 purchases ($0) and 1 sale ($547.8K). The largest single trade was a sale of 7,304 shares of Halozyme Therapeutics, INC. worth $547.8K, dated 2026-06-29. The first filing on our record is dated 2022-04-05 and the latest 2026-06-30.
Halozyme Therapeutics, INC. (HALO)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2026-06-29 | S, sale reported on Form 4 | 7,304 | $547.8K | 2026-06-30 |
KDNY
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2023-04-04 | S, sale reported on Form 4 | 924 | $21.3K | 2023-04-04 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1866746) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms